Home › Stocks › ARQT

Arcutis Biotherapeutics, Inc. (ARQT): insider buying, hedge funds & Congress trades

Arcutis Biotherapeutics, Inc. (ARQT): 9 insider purchases in the last two years; 6 trades disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
Jun 17, 2025Heron Patrick J
Director
2,646$13.08$34.6Kno history
Jun 6, 2025Heron Patrick J
Director
2,268$13.33$30.2Kno history
May 23, 2025Heron Patrick J
Director
5,040$13.65$68.8Kno history
May 19, 2025Heron Patrick J
Director
2,520$13.62$34.3Kno history
May 15, 2025Heron Patrick J
Director
8,674$13.76$119.4Kno history
May 13, 2025Heron Patrick J
Director
6,300$13.60$85.7Kno history
Dec 3, 2024Watanabe Todd Franklin
Director, Officer
6,038$3.52$21.3Kroutine
Dec 3, 2024Matsuda Masaru
Officer
5,657$3.28$18.5Kno history
Dec 3, 2024Edwards Larry Todd
Officer
1,093$7.11$7.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for ARQT

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in ARQT

FiledMemberTypeAmount
Jun 8, 2026Gilbert Cisnerospurchase$1,001 - $15,000
Apr 7, 2026Gilbert Cisnerospurchase$1,001 - $15,000
Jan 12, 2026Gilbert Cisnerospartial sale$1,001 - $15,000
Oct 15, 2023Josh Gottheimersale$1,001 - $15,000
May 19, 2023Josh Gottheimerpurchase$1,001 - $15,000
Jul 22, 2022Josh Gottheimerpurchase$1,001 - $15,000